{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:48:07Z","timestamp":1785523687872,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2023-01942"],"award-info":[{"award-number":["2023-01942"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016670","name":"Region \u00d6sterg\u00f6tland","doi-asserted-by":"publisher","award":["R\u00d6 1012239"],"award-info":[{"award-number":["R\u00d6 1012239"]}],"id":[{"id":"10.13039\/100016670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AR082562"],"award-info":[{"award-number":["R01AR082562"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR082562"],"award-info":[{"award-number":["R01AR082562"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR082562"],"award-info":[{"award-number":["R01AR082562"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["R01AR082562"],"award-info":[{"award-number":["R01AR082562"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003945","name":"Link\u00f6ping University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"DOI":"10.1007\/s00198-026-08144-w","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:10:29Z","timestamp":1785219029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Manual chart review reveals bisphosphonate exposure misclassification in atypical femur fracture patients: auditing medical records in two international cohorts"],"prefix":"10.1007","author":[{"given":"Rickard","family":"Sand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec D.","family":"Gilfillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denison S.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sp\u00e5ngeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Peter","family":"B\u00f6gl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Wezenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0677-9265","authenticated-orcid":false,"given":"J\u00f6rg","family":"Schilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"issue":"Suppl 2","key":"8144_CR1","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1007\/s00586-003-0622-z","volume":"12","author":"H Fleisch","year":"2003","unstructured":"Fleisch H (2003) Bisphosphonates in osteoporosis. Eur Spine J 12(Suppl 2):S142-146","journal-title":"Eur Spine J"},{"key":"8144_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bone.2016.05.013","volume":"89","author":"J Sanderson","year":"2016","unstructured":"Sanderson J, Martyn-St James M, Stevens J, Goka E, Wong R, Campbell F, Selby P, Gittoes N, Davis S (2016) Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: a systematic review and network meta-analysis. Bone 89:52\u201358","journal-title":"Bone"},{"key":"8144_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","volume":"383","author":"DM Black","year":"2020","unstructured":"Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL (2020) Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med 383:743\u2013753","journal-title":"N Engl J Med"},{"key":"8144_CR4","doi-asserted-by":"publisher","first-page":"e2141","DOI":"10.1210\/clinem\/dgae023","volume":"109","author":"DC Bauer","year":"2024","unstructured":"Bauer DC, Black DM, Dell R, Fan B, Smith CD, Ernst MT, Jurik AG, Fr\u00f8kj\u00e6r JB, Boesen M, Vittinghoff E, Abrahamsen B (2024) Bisphosphonate use and risk of atypical femoral fractures: a Danish case cohort study with blinded radiographic review. J Clin Endocrinol Metab 109:e2141\u2013e2150","journal-title":"J Clin Endocrinol Metab"},{"key":"8144_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3109\/17453674.2015.1004149","volume":"86","author":"J Schilcher","year":"2015","unstructured":"Schilcher J, Koeppen V, Aspenberg P, Micha\u00eblsson K (2015) Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop 86:100\u2013107","journal-title":"Acta Orthop"},{"key":"8144_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/archinternmed.2012.1796","volume":"172","author":"RP Meier","year":"2012","unstructured":"Meier RP, Perneger TV, Stern R, Rizzoli R, Peter RE (2012) Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med 172:930\u2013936","journal-title":"Arch Intern Med"},{"key":"8144_CR7","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/jbmr.1719","volume":"27","author":"RM Dell","year":"2012","unstructured":"Dell RM, Adams AL, Greene DF, Funahashi TT, Silverman SL, Eisemon EO, Zhou H, Burchette RJ, Ott SM (2012) Incidence of atypical nontraumatic diaphyseal fractures of the femur. J Bone Miner Res 27:2544\u20132550","journal-title":"J Bone Miner Res"},{"key":"8144_CR8","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/jbmr.1550","volume":"27","author":"AC Feldstein","year":"2012","unstructured":"Feldstein AC, Black D, Perrin N, Rosales AG, Friess D, Boardman D, Dell R, Santora A, Chandler JM, Rix MM, Orwoll E (2012) Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res 27:977\u2013986","journal-title":"J Bone Miner Res"},{"key":"8144_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bone.2012.02.632","volume":"51","author":"JC Lo","year":"2012","unstructured":"Lo JC, Huang SY, Lee GA, Khandelwal S, Provus J, Ettinger B, Gonzalez JR, Hui RL, Grimsrud CD (2012) Clinical correlates of atypical femoral fracture. Bone 51:181\u2013184","journal-title":"Bone"},{"key":"8144_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.injury.2017.05.033","volume":"48","author":"JW Kim","year":"2017","unstructured":"Kim JW, Kim JJ, Byun YS, Shon OJ, Oh HK, Park KC, Kim JW, Oh CW (2017) Factors affecting fracture location in atypical femoral fractures: a cross-sectional study with 147 patients. Injury 48:1570\u20131574","journal-title":"Injury"},{"key":"8144_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1210\/er.2018-00001","volume":"40","author":"DM Black","year":"2019","unstructured":"Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N (2019) Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management. Endocr Rev 40:333\u2013368","journal-title":"Endocr Rev"},{"key":"8144_CR12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00198-019-04869-z","volume":"30","author":"ES LeBlanc","year":"2019","unstructured":"LeBlanc ES, Rosales AG, Genant HK, Dell RM, Friess DM, Boardman DL, Santora AC, Bauer DC, de Papp AE, Black DM, Orwoll ES (2019) Radiological criteria for atypical features of femur fractures: what we can learn when applied in a clinical study setting. Osteoporos Int 30:1287\u20131295","journal-title":"Osteoporos Int"},{"key":"8144_CR13","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/jbmr.3221","volume":"32","author":"ES LeBlanc","year":"2017","unstructured":"LeBlanc ES, Rosales AG, Black DM, Genant HK, Dell RM, Friess DM, Boardman DL, Bauer DC, de Papp AE, Santora AC, Orwoll ES (2017) Evaluating atypical features of femur fractures: how change in radiological criteria influenced incidence and demography of atypical femur fractures in a community setting. J Bone Miner Res 32:2304\u20132314","journal-title":"J Bone Miner Res"},{"key":"8144_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/17453674.2021.1891512","volume":"92","author":"G Zdolsek","year":"2021","unstructured":"Zdolsek G, Chen Y, B\u00f6gl HP, Wang C, Woisetschl\u00e4ger M, Schilcher J (2021) Deep neural networks with promising diagnostic accuracy for the classification of atypical femoral fractures. Acta Orthop 92:394\u2013400","journal-title":"Acta Orthop"},{"key":"8144_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/02841851241313026","author":"HP B\u00f6gl","year":"2025","unstructured":"B\u00f6gl HP, Schilcher J (2025) Identification of subtrochanteric and femoral shaft fractures as atypical femur fractures on radiology reports. Acta Radiol. https:\/\/doi.org\/10.1177\/02841851241313026","journal-title":"Acta Radiol"},{"key":"8144_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/17453674.2012.718517","volume":"83","author":"A Rydholm","year":"2012","unstructured":"Rydholm A (2012) Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed! Acta Orthop 83:319\u2013320","journal-title":"Acta Orthop"},{"key":"8144_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323","journal-title":"J Bone Miner Res"},{"key":"8144_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3365","volume":"353","author":"B Abrahamsen","year":"2016","unstructured":"Abrahamsen B, Eiken P, Prieto-Alhambra D, Eastell R (2016) Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study. BMJ 353:i3365","journal-title":"BMJ"},{"key":"8144_CR19","first-page":"188","volume":"4","author":"A Burden","year":"2015","unstructured":"Burden A (2015) Examining exposure misclassification of oral bisphosphonate therapy and the associated fracture risk: a cohort study. Adv Pharmacoepidemiol Drug Saf 4:188","journal-title":"Adv Pharmacoepidemiol Drug Saf"},{"key":"8144_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jbi.2011.11.006","volume":"45","author":"L Zhou","year":"2012","unstructured":"Zhou L, Plasek JM, Mahoney LM, Chang FY, DiMaggio D, Rocha RA (2012) Mapping partners master drug dictionary to RxNorm using an NLP-based approach. J Biomed Inform 45:626\u2013633","journal-title":"J Biomed Inform"},{"key":"8144_CR21","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/bcp.13206","volume":"83","author":"SM Wallerstedt","year":"2017","unstructured":"Wallerstedt SM, Hoffmann M (2017) Evaluating beneficial drug effects in a non-interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data. Br J Clin Pharmacol 83:1309\u20131318","journal-title":"Br J Clin Pharmacol"},{"key":"8144_CR22","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.2106\/JBJS.23.01439","volume":"106","author":"PA Anderson","year":"2024","unstructured":"Anderson PA, Kates SL, Watts NB (2024) Update on atypical femoral fractures. J Bone Joint Surg Am 106:1819\u20131828","journal-title":"J Bone Joint Surg Am"},{"key":"8144_CR23","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","volume":"364","author":"J Schilcher","year":"2011","unstructured":"Schilcher J, Micha\u00eblsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 364:1728\u20131737","journal-title":"N Engl J Med"},{"key":"8144_CR24","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.5435\/JAAOS-D-22-00476","volume":"31","author":"BW Diffenderfer","year":"2023","unstructured":"Diffenderfer BW, Wang Y, Pearman L, Pyrih N, Williams SA (2023) Real-world management of patients with osteoporosis at very high risk of fracture. J Am Acad Orthop Surg 31:e327\u2013e335","journal-title":"J Am Acad Orthop Surg"},{"key":"8144_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116455","volume":"162","author":"LU Gani","year":"2022","unstructured":"Gani LU, Anthony NF, Dacay LM, Tan PT, Chong LR, King TFJ (2022) Characteristics of bisphosphonate and non-bisphosphonate related atypical femoral fracture in a South East Asian population - secondary analysis. Bone 162:116455","journal-title":"Bone"},{"key":"8144_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","volume":"85","author":"JC Lo","year":"2016","unstructured":"Lo JC, Hui RL, Grimsrud CD, Chandra M, Neugebauer RS, Gonzalez JR, Budayr A, Lau G, Ettinger B (2016) The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone 85:142\u2013147","journal-title":"Bone"},{"key":"8144_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson JF, Almqvist C, Bonamy AK, Ljung R, Micha\u00eblsson K, Neovius M, Stephansson O, Ye W (2016) Registers of the Swedish total population and their use in medical research. Eur J Epidemiol 31:125\u2013136","journal-title":"Eur J Epidemiol"},{"key":"8144_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/jbmr.4498","volume":"37","author":"B Freyschuss","year":"2022","unstructured":"Freyschuss B, Svensson MK, Cars T, Lindhagen L, Johansson H, Kindmark A (2022) Real-world effectiveness of anti-resorptive treatment in patients with incident fragility fractures-the STORM cohort-a Swedish retrospective observational study. J Bone Miner Res 37:649\u2013659","journal-title":"J Bone Miner Res"},{"key":"8144_CR29","first-page":"23126","volume":"121","author":"K Modig","year":"2024","unstructured":"Modig K, Meyer A, Ek S, S\u00e4\u00e4f M, Hedstr\u00f6m M (2024) Prescription of osteoporosis drugs and secondary fracture prevention still at low levels and with large regional variation. Lakartidningen 121:23126","journal-title":"Lakartidningen"},{"key":"8144_CR30","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration (2024) Real-world data: assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products: Guidance for Industry 16\u201320"},{"key":"8144_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2340\/17453674.2025.44329","volume":"96","author":"J Schilcher","year":"2025","unstructured":"Schilcher J (2025) Perspective: the misleading label of atypical femur fracture: a call for diagnostic clarity amid biological diversity. Acta Orthop 96:584\u2013586","journal-title":"Acta Orthop"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08144-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:27:30Z","timestamp":1785518850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-08144-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":31,"alternative-id":["8144"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08144-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Annette L. Adams served as unpaid executive committee member, board member, and elected officer for American College of Epidemiology. Anna Sp\u00e5ngeus received consulting fees from Gideon Richter (company) and payments for honoraria for lectures from Union Chimique Belge (UCB), Merch Sharp\u00a0&\u00a0Dohme (MSD), Astra Zeneca, Sandoz, and Applied Molecular Genetics (AMGEN) (companies); served on an advisory board for UCB; and has had unpaid leadership or fiduciary roles in Swedish Osteoporosis Society and Fragility Fracture Network Sweden. J\u00f6rg Schilcher has received consulting fees from Sectra AB, LINK Sweden AB, DePuy Synthes, and Stryker (companies) and payments for honoraria for lectures from Stryker and LINK (companies) and as an Associate Editor of Bone Reports (Elsevier) and has had unpaid leadership or fiduciary roles as a board member of the American Society for Bone and Mineral Research Atypical Femur Fracture Task Force and a member of the Swedish Fracture Register research group for registry-randomised studies and member of the Swedish Joint Replacement Register steering group. The remaining authors have no competing interests to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}